Authors


Coleman Drake, PhD

Latest:

Comparison of Primary Payer in Cancer Registry and Discharge Data

Enrollment in managed care among Medicaid enrollees presents challenges to classifying Medicaid coverage in cancer registries.



Stephanie Fortier, PhD

Latest:

Oncologists’ Perceptions and Utilization of US Therapeutic Oncology Biosimilars

Biosimilar use in clinical practice is determined by oncologists’ perceptions of and willingness to prescribe them. The authors investigated US oncologists’ perceptions and use of biosimilars.


Maciej M. Mrugala, MD, PhD

Latest:

Lessons From Previously Used Therapies In NF1-PN

Panelists discuss key lessons learned from previous NF1-associated plexiform neurofibroma therapies, including the limitations of traditional treatments due to high toxicity and limited efficacy, and how these challenges are driving the development of more targeted therapies like MEK inhibitors, personalized medicine, and combination strategies to improve outcomes and reduce relapse.


Anna Alonzo, BS

Latest:

Implementation of the Accountable Health Communities Model in Arizona

The Accountable Health Communities Model facilitates multisector coordination. Implementation science elucidated the contextual factors that facilitated the use of this model in Arizona.



Siyuan Shen, MCIT

Latest:

The Implementation of Opioid Prescribing Report Cards in Medicaid Managed Care: A Community Quality Collaborative

This article describes the Philadelphia Medicaid Opioid Prescribing Initiative that was launched by a multidisciplinary team and mailed local Medicaid providers individualized prescribing report cards.


Emma L. Tucher, PhD

Latest:

The Impacts of Supplemental Benefits on Medicare Advantage Plan Composition

After evaluating the association between the expanded Medicare Advantage supplemental benefits and plan composition, authors determined that adoption was not associated with large demographic shifts in enrollment.


Anjum Khurshid, MD, PhD

Latest:

Assessment of Structured Data Elements for Social Risk Factors

An expert panel identified and assessed electronic health record and health information exchange structured data elements to support future development of social risk factor computable phenotyping.


Darlene Dobkowski, MA

Latest:

Osimertinib Combo Lessens CNS Progression in EGFR NSCLC

Central nervous system (CNS) progression was reduced with osimertinib plus chemotherapy for patients with EGFR-mutated non-small cell lung cancer plus CNS metastases.


Mim Senft.
Mim Senft

Latest:

Contributor: Companies Can’t Afford a She-cession

As working women have been disproportionately impacted by COVID-19, solutions to address what has been coined a “she-cession” include targeted communications, flexible work schedules, and increased education/tutoring resources.


George Bakris, MD

Latest:

Glucose-Lowering Treatment Patterns in Patients With Diabetic Kidney Disease

Real-world treatment of diabetic kidney disease in the United States, based on national-level health care claims and electronic health records data, is inconsistent with the current guidelines.


Ryan Sterling, PhD

Latest:

Factors Associated With Primary Care Physician Turnover in the VA

This longitudinal observational study found higher team satisfaction with workload to be significantly associated with lower primary care physician turnover.


Jacinda Mawson Nicklas, MD, MPH, MA

Latest:

Taking a Cardiometabolic Health Approach in Patients with Type 2 Diabetes

Panelists discuss how implementing cardiovascular-kidney-metabolic health requires a team-based approach using the analogy of football, where physicians coach multidisciplinary teams to help patients overcome barriers and achieve health goals.


Christopher Tjoa, MD

Latest:

The Implementation of Opioid Prescribing Report Cards in Medicaid Managed Care: A Community Quality Collaborative

This article describes the Philadelphia Medicaid Opioid Prescribing Initiative that was launched by a multidisciplinary team and mailed local Medicaid providers individualized prescribing report cards.


Giovanni Cucchiaro, MD

Latest:

Preappointment Surveys and Reminder Calls to Improve Show Rate

Patients who completed a preappointment survey were significantly more likely to attend their clinic appointment than noncompleters and spent significantly less time in their appointment.


Terence S. Dermody, MD

Latest:

Consumer-Centric Approach to Enhance Access to Pediatric Specialty Care

The authors’ organization optimized scheduling techniques that improved patient access to pediatric specialists to within 7 calendar days for new patients.


Allison Brennan, MPP

Latest:

CMS Needs to Rethink How Medicare Assesses Quality

Late 2020 changes make accountable care organizations a canary in the coal mine.


Ami Vyas, PhD, MS, MBA

Latest:

Association of Guideline-Concordant Care With Survival, Health Care Utilization, and Costs Among Older Women With Advanced Epithelial Ovarian Cancer

Non–guideline-concordant care for ovarian cancer was associated with higher all-cause and cancer-specific mortality, increased health care utilization, and increased Medicare expenditures, highlighting opportunities for improving cancer care in this vulnerable group.


Milam Ford, BS

Latest:

Reduced Medical Spending Associated With Integrated Pharmacy Benefits

Members covered by an integrated pharmacy benefit (as opposed to a pharmacy carve-out) experienced slower growth in medical spending.


Khrista Achtermann, MHA

Latest:

Managing Total Knee Replacement Under Value-Based Payments

This article describes the approach that a large primary care group at risk for value-based payments chose to deploy in managing clinical and financial outcomes of knee osteoarthritis jointly with orthopedic surgeons.


Crystal Aguh, MD, FAAD

Latest:

Bridging Education Gaps in Treatment for Scarring Alopecia With Innovative Approaches

Crystal Aguh, MD, FAAD, Johns Hopkins School of Medicine faculty, highlights the critical need for comprehensive education on hair loss across diverse hair types, stressing the importance of understanding inflammatory pathways for developing targeted therapies.


Jeff Stark, MD | Image Credit: © UCB
Jeff Stark, MD

Latest:

Dr Jeff Stark: New Bimzelx Dose Offers Simplicity and Choice

On October 14, 2024, the FDA approved a 320-mg single dose of bimekizumab-bkzx (Bimzelx; UCB) in a 2-mL prefilled syringe and autoinjector; both forms are now commercially available in the US.


Emmie Harcourt, MPA

Latest:

Provider Capacity During Medicaid Expansion and a Public Health Emergency

This survey study finds that most Missouri Medicaid providers had capacity for new patients, even during a period of unprecedented Medicaid enrollment growth.


Jamie L. Koprivnikar, MD

Latest:

Financial Considerations Influencing Treatment Strategies in PNH Treatment Pathway

The panelists provide their final thoughts, highlighting financial considerations in PNH treatment.


Katherine Kwon, MD

Latest:

A Standardized Care Pathway Increases Optimal Dialysis Starts

The authors observed a significant increase in optimal starts for dialysis and in peritoneal dialysis rates after implementing a standardized end-stage renal disease transition pathway.


Shipra Singh, MBBS, PhD, MPH

Latest:

Association of Social Risks With Avoiding or Delaying Health Care and With Emergency Department Visits: Evidence From 2017 Ohio Medicaid Assessment Survey

Social risks (food insecurity, housing instability, financial strain, health insurance type) are associated with patients’ decisions to avoid/delay health care and increased utilization of the emergency department.


Monjori Mukerjee, BSc

Latest:

Implementing Team-Based Telemedicine Workflows in Safety-Net Primary Care

Telemedicine in safety-net primary care faces particular challenges. Consistent, team-based workflows can support video visit implementation and health care maintenance in telemedicine visits.


Barry Byrne, MD | image credit: research.pediatrics.med.ufl.edu
Barry Byrne, MD, PhD

Latest:

The Value of Newborn Screening for DMD: Barry Byrne, MD, PhD

Barry Byrne, MD, PhD, Powell Gene Therapy Center at the University of Florida, discusses gene therapy considerations for pediatric patients and how newborn screening can influence outcomes for patients with Duchenne muscular dystrophy (DMD).


AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo